Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report) and Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, earnings, dividends, analyst recommendations, institutional ownership and valuation. Profitability This table compares Fulcrum Therapeutics and Vertex […]
Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report) had its target price boosted by stock analysts at The Goldman Sachs Group from $5.00 to $6.00 in a report released on Thursday, Benzinga reports. The firm presently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective would indicate a potential downside of 13.67% […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 3,670,000 shares, a growth of 10.2% from the December 15th total of 3,330,000 shares. Based on an average daily volume of 567,300 shares, the short-interest ratio […]
Denali Advisors LLC Takes Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.